Determination of plasma salbutamol concentrations after nebulization in a pediatric emergency department
- PMID: 17762901
- DOI: 10.2223/JPED.1689
Determination of plasma salbutamol concentrations after nebulization in a pediatric emergency department
Abstract
Objectives: To partially validate the methodology for determining salbutamol in human plasma through high-efficiency liquid chromatography and fluorescence detection. To analyze plasma salbutamol concentrations in a group of pediatric patients with indication for nebulization in the emergency room.
Method: Analytical, prospective cross-sectional case series. Fifteen patients aged 12 to 37 months with a diagnosis of acute asthma crisis were selected at the Pediatric Emergency Service at Hospital da Criança Santo Antônio - Complexo Hospitalar Santa Casa, Porto Alegre, Brazil. The patients were treated following the unit's routine for the management of acute asthma crises: nebulization with salbutamol (flow rate of 6-8 L/min) (0.15 mg/kg) suspended in 4 mL of 0.9% saline solution. Nebulization was administered sequentially, three times, at 20 minute intervals. All patients were given prednisolone orally (1 mg/kg) concurrently with the nebulizations.
Results: Plasma concentrations exhibited great variability in acute asthma crisis patients given three nebulizations of salbutamol (0.15 mg/kg). The mean level in plasma was 12.09 +/- 10.8 ng/mL, with a median of 8.9 ng/mL (IQ25-75% 2.75-17.65). The sample's coefficient of variation was 92.4%.
Conclusions: Post-inhalation plasma salbutamol concentrations exhibit great variation in the pediatric population, as seen in other studies. The possible causes and implications of this finding remain the subject of disagreements and of further assessments.
Similar articles
-
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?Eur J Clin Pharmacol. 2010 Jun;66(6):605-10. doi: 10.1007/s00228-010-0787-4. Epub 2010 Feb 27. Eur J Clin Pharmacol. 2010. PMID: 20195589 Clinical Trial.
-
Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer.Am J Emerg Med. 1998 Nov;16(7):637-42. doi: 10.1016/s0735-6757(98)90164-4. Am J Emerg Med. 1998. PMID: 9827736 Clinical Trial.
-
Salbutamol via metered-dose inhaler with spacer versus nebulization for acute treatment of pediatric asthma in the emergency department.Pediatr Emerg Care. 2004 Oct;20(10):656-9. doi: 10.1097/01.pec.0000142948.73512.81. Pediatr Emerg Care. 2004. PMID: 15454738
-
Development of the siriraj clinical asthma score.Asian Pac J Allergy Immunol. 2013 Sep;31(3):210-6. Asian Pac J Allergy Immunol. 2013. PMID: 24053703 Review.
-
International expert opinion on the use of nebulization for pediatric asthma therapy during the COVID-19 pandemic.J Thorac Dis. 2021 Jul;13(7):3934-3947. doi: 10.21037/jtd-21-841. J Thorac Dis. 2021. PMID: 34422324 Free PMC article. Review. No abstract available.
Cited by
-
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence?Eur J Clin Pharmacol. 2010 Jun;66(6):605-10. doi: 10.1007/s00228-010-0787-4. Epub 2010 Feb 27. Eur J Clin Pharmacol. 2010. PMID: 20195589 Clinical Trial.
-
Electrochemical Discrimination of Salbutamol from Its Excipients in VentolinTM at Nanoporous Gold Microdisc Arrays.Sensors (Basel). 2021 Jun 9;21(12):3975. doi: 10.3390/s21123975. Sensors (Basel). 2021. PMID: 34207616 Free PMC article.